blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3185856

EP3185856 - PLURIMODAL RELEASE FORMULATION OF DOXYLAMINE AND PYRIDOXINE AND/OR METABOLITES OR SALTS THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.03.2019
Database last updated on 16.11.2024
FormerThe patent has been granted
Status updated on  20.04.2018
FormerGrant of patent is intended
Status updated on  13.04.2018
FormerRequest for examination was made
Status updated on  14.02.2018
FormerGrant of patent is intended
Status updated on  03.01.2018
FormerRequest for examination was made
Status updated on  02.06.2017
FormerThe international publication has been made
Status updated on  27.02.2017
Most recent event   Tooltip04.12.2020Lapse of the patent in a contracting state
New state(s): SI
published on 06.01.2021  [2021/01]
Applicant(s)For all designated states
Duchesnay Inc.
950 Boul. Michèle-Bohec
Blainville, Québec J7C 5E2 / CA
[2017/27]
Inventor(s)01 / VRANDERICK, Manon
407 Du Calypso
St-Lazare, Québec J7T 3E9 / CA
02 / ST-ONGE, Jean-Luc
13370 A.-David
Mirabel, Québec J7J 1T6 / CA
03 / GALLO, Michele
88 Hector-Joly
Blainville, Québec J7C 0E2 / CA
04 / GERVAIS, Éric
5 De Rochebonne
Blainville, Québec J7B 1W8 / CA
 [2017/27]
Representative(s)Plasseraud IP
104 Rue de Richelieu
CS92104
75080 Paris Cedex 02 / FR
[N/P]
Former [2018/21]Cabinet Plasseraud
66, rue de la Chaussée d'Antin
75440 Paris Cedex 09 / FR
Former [2017/27]Cabinet Plasseraud
66 rue de la Chaussée d'Antin
75440 Paris Cedex 09 / FR
Application number, filing date14900963.129.08.2014
[2017/27]
WO2014CA50828
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016029290
Date:03.03.2016
Language:EN
[2016/09]
Type: A1 Application with search report 
No.:EP3185856
Date:05.07.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 03.03.2016 takes the place of the publication of the European patent application.
[2017/27]
Type: B1 Patent specification 
No.:EP3185856
Date:23.05.2018
Language:EN
[2018/21]
Search report(s)International search report - published on:CA03.03.2016
(Supplementary) European search report - dispatched on:EP17.08.2017
ClassificationIPC:A61K9/28, A61K31/4402, A61K31/4415, A61K9/32, A61K9/42, A61P1/08
[2017/27]
CPC:
A61K31/4415 (EP,EA,KR); A61K9/209 (KR); A61K9/2886 (EP,EA);
A61K31/4402 (EP,EA,KR); A61K9/2027 (KR); A61K9/2846 (KR);
A61K9/2866 (KR); A61K9/5073 (KR); A61P1/08 (EP);
A61P15/00 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/4402, A61K2300/00 (EP);
A61K31/4415, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/27]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:MULTIMODALE ABLÖSEFORMULIERUNG AUS DOXYLAMIN UND PYRIDOXIN UND/ODER METABOLITEN ODER SALZEN DAVON[2017/27]
English:PLURIMODAL RELEASE FORMULATION OF DOXYLAMINE AND PYRIDOXINE AND/OR METABOLITES OR SALTS THEREOF[2017/27]
French:FORMULATION À LIBÉRATION PLURIMODALE À BASE DE DOXYLAMINE ET DE PYRIDOXINE ET/OU DE MÉTABOLITES OU DE SELS ASSOCIÉS[2017/27]
Entry into regional phase27.02.2017National basic fee paid 
27.02.2017Search fee paid 
27.02.2017Designation fee(s) paid 
27.02.2017Examination fee paid 
Examination procedure27.02.2017Examination requested  [2017/27]
27.02.2017Date on which the examining division has become responsible
20.09.2017Amendment by applicant (claims and/or description)
04.01.2018Communication of intention to grant the patent
12.02.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.02.2018Fee for grant paid
12.02.2018Fee for publishing/printing paid
12.04.2018Information about intention to grant a patent
12.04.2018Receipt of the translation of the claim(s)
Opposition(s)26.02.2019No opposition filed within time limit [2019/18]
Fees paidRenewal fee
27.02.2017Renewal fee patent year 03
02.06.2017Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL23.05.2018
EE23.05.2018
HR23.05.2018
LT23.05.2018
LV23.05.2018
MK23.05.2018
RO23.05.2018
RS23.05.2018
SK23.05.2018
SM23.05.2018
BG23.08.2018
MT29.08.2018
SI29.08.2018
[2021/01]
Former [2020/31]AL23.05.2018
EE23.05.2018
HR23.05.2018
LT23.05.2018
LV23.05.2018
MK23.05.2018
RO23.05.2018
RS23.05.2018
SK23.05.2018
SM23.05.2018
BG23.08.2018
MT29.08.2018
Former [2020/08]AL23.05.2018
EE23.05.2018
HR23.05.2018
LT23.05.2018
LV23.05.2018
RO23.05.2018
RS23.05.2018
SK23.05.2018
SM23.05.2018
BG23.08.2018
MT29.08.2018
Former [2019/51]AL23.05.2018
EE23.05.2018
HR23.05.2018
LT23.05.2018
LV23.05.2018
RO23.05.2018
RS23.05.2018
SK23.05.2018
SM23.05.2018
BG23.08.2018
Former [2019/11]EE23.05.2018
HR23.05.2018
LT23.05.2018
LV23.05.2018
RO23.05.2018
RS23.05.2018
SK23.05.2018
SM23.05.2018
BG23.08.2018
Former [2019/10]EE23.05.2018
HR23.05.2018
LT23.05.2018
LV23.05.2018
RO23.05.2018
RS23.05.2018
SK23.05.2018
BG23.08.2018
Former [2019/09]EE23.05.2018
HR23.05.2018
LT23.05.2018
LV23.05.2018
RS23.05.2018
BG23.08.2018
Former [2018/51]HR23.05.2018
LT23.05.2018
LV23.05.2018
RS23.05.2018
BG23.08.2018
Former [2018/50]HR23.05.2018
LT23.05.2018
BG23.08.2018
Former [2018/47]LT23.05.2018
Documents cited:Search[Y]WO2013082706  (PHARMASCIENCE INC [CA], et al) [Y] 1-27 * page 5; example 1; claims 1-33 *;
 [Y]  - SVETLANA MADJUNKOVA ET AL, "The Delayed-Release Combination of Doxylamine and Pyridoxine (Diclegis /Diclectin ) for the Treatment of Nausea and Vomiting of Pregnancy", PAEDIATRIC DRUGS, NZ, (20140227), vol. 16, no. 3, doi:10.1007/s40272-014-0065-5, ISSN 1174-5878, pages 199 - 211, XP055395993 [Y] 1-27 * the whole document *

DOI:   http://dx.doi.org/10.1007/s40272-014-0065-5
International search[Y]CA2316277  (MERCK PATENT GMBH [DE]) [Y] 1-46 and 48-49* The whole document *;
 [Y]CA2350195  (DUCHESNAY INC [CA]) [Y] 1-46 and 48-49 * The whole document *;
 [Y]WO2013123569  (DUCHESNAY INC [CA], et al) [Y] 1-46 and 48-49 * The whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.